• English
  • Français
  • Español
  • Facebook
  • RSS
  • Twitter

Therapeutics Initiative

Independent Healthcare Evidence

  • TI
  • About Us
    • Oversight Committee
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
    • Questions & Answers
  • Therapeutics Letter
  • Our Evidence Reviews
  • Portrait
  • Continuing Education
  • Contact Us
  • Subscribe
Home > Education > [Jan 27] TI Methods Speaker Series: On the difficulties in determining the lethality of COVID-19 and the various ways in which Bayesian methods can help

[Jan 27] TI Methods Speaker Series: On the difficulties in determining the lethality of COVID-19 and the various ways in which Bayesian methods can help

January 11, 2021 Education, Podcasts & Videos Leave a Comment

Share

TI Methods Speaker Series

The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health, UBC Point Grey Campus. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. 


WHEN: Wednesday, January 27th, 2021 from 12:00 to 1:00 PM PDT [click here to convert to your local time]

WHERE: Offered online using Zoom.

TITLE: On the difficulties in determining the lethality of COVID-19 and the various ways in which Bayesian methods can help

SPEAKER: Harlan Campbell, Postdoctoral Research Fellow, Department of Statistics, University of British Columbia.


This event has already taken place. Scroll down to see the video recording.


About the topic: Early on during the COVID-19 pandemic, researchers had tremendous difficulty understanding the lethality of the novel corona virus.  In this talk I review the main reasons why estimating the infection fatality rate (IFR) is so challenging and discuss how Bayesian models can help address these challenges.  Specifically, I consider a Bayesian model developed for estimating the IFR and it’s association with different variables of interest.  When the model was fit to European data from May 2020, the overall COVID-19 IFR was estimated to be 0.47%, 95% C.I. = [0.34%, 0.63%] and a significant relationship was established between the infection rate in a given country and the time between that country’s first reported infection and the imposition of social distancing measures. See https://arxiv.org/abs/2005.08459 for more.

About the speaker: Harlan Campbell is a postdoctoral research fellow in statistics at the University of British Columbia with funding from from ReCoDID (https://recodid.eu/) and the WHO (https://www.who.int/reproductivehealth/projects/ZIKV-IPD-MA.pdf). Dr. Campbell’s work focusses on questions of meta-research and statistical methods for measurement error, evidence synthesis and equivalence testing.

About the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic, while physical distancing measures are in effect, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.

https://www.ti.ubc.ca/wordpress/wp-content/uploads/2021/01/TIMSS-27Jan2021-HCampbell.mp4

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

 

  • About Us
    • Oversight Committee
    • Questions & Answers
    • Steering Committee
    • Working Groups
      • Drug Assessment
      • Education
      • PharmacoEpidemiology
      • Cochrane Hypertension
    • Members
    • TI Surveys
  • Portrait
    • Frequently Asked Questions
    • Portrait Contact
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
    • Best Evidence
  • Contact Us
  • Terms & Policies
    • Legal Information & Terms of Use
    • Privacy Policy
    • Acceptable Use Policy

Categories

  • News (123)
  • Therapeutics Letter (133)
  • Portrait (1)
  • Drug Assessments (39)
  • PharmacoEpidemiology (75)
  • Podcasts & Videos (52)

Recent Seminars

[Mar 10] Therapeutics Initiative Virtual Workshop – Using Evidence in Shared Decision Making: A Case-based, Critical Appraisal Approach for Busy Clinicians

Register
Share

[Mar 17] Therapeutics Initiative Best Evidence Webinar: Withdrawal of antihypertensive drugs in older people

Register
Share

[Mar 31] TI Methods Speaker Series: The development of a risk of bias tool for network meta-analysis

Register
Share

Therapeutics Initiative

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. Read more Donate

Contact

2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3
Contact us
Office: +1 604-822-0700
Fax: +1 604-822-0701

UBC logoISDB logo

Subscribe

Subscribe to receive email notifications from the TI about the Therapeutics Letter, upcoming educational events, personal prescribing portraits and other news and recent publications. SUBSCRIBE

© 1994 - 2021 Therapeutics Initiative · Terms & Policies · TM